Modifications of apoptin

Details Modifications of apoptin Modifications of apoptin

2008-01-15

2008-01-15

Ketter, James (Department: 1636)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

C435S320100

Reexamination Certificate

active

07319034

ABSTRACT:
Phosphorylated Apoptin is described. Apoptin is tumor-specifically phosphorylated and part of the Apoptin apoptotic pathway in tumor cells is elucidated. New therapeutic possibilities, for example, novel therapeutic compounds that can work alone or, sequentially to, or jointly with other known compounds. Also, the use of tumor-specifically phosphorylation of Apoptin for diagnostic purposes is described. Such a diagnostic purpose can, for example, be a method for detecting the presence of cancer cells or cells that are cancer prone or a method to identify a putative cancer inducing agent or a method for the in vitro treatment effect of Apoptin on tumor cells by testing the phosphorylation state of Apoptin. Even more, the invention provides possibilities to further elucidate the apoptotic pathway and to identify for example crucial mediators of phosphorylation in human tumor cells. Interfering with such a mediator could provide new anti-cancer therapies.

REFERENCES:
patent: 5491073 (1996-02-01), Noteborn et al.
patent: WO9503414 (1995-02-01), None
patent: WO 96/41191 (1996-12-01), None
patent: WO 98/46740 (1998-10-01), None
patent: WO 99/08108 (1999-02-01), None
patent: WO 99/28461 (1999-06-01), None

Affiliated with

Also associated with

Rating

Modifications of apoptin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modifications of apoptin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modifications of apoptin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2812323